Articles

Podcasts

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Results show how patients with psoriatic arthritis prioritize their decisions when choosing medication.

Biologic Treatment Preferences Revealed Among Psoriatic Arthritis Patients

Investigators found that patients who were not treated with biologic medications were at a significantly increased risk of developing psoriatic arthritis.

Biologic Treatment Effective in Psoriatic Arthritis Prevention

Dr. Blauvelt speaks on the results of the phase 3b Heads Up study, and the future of upadacitinib and dupilumab in atopic dermatitis management.

Andrew Blauvelt, MD, MBA: The “New Era” of Dermatological Drugs

Researchers record more depressive symptoms in patients with psoriatic arthritis, which they believe incentivizes doctors to utilize screening methods that focus on the mental health of a patient.

Comorbid Psoriatic Arthritis Generally Worsens Psoriasis Severity

Researchers from France challenge previous reports of the IL-17 inhibitor treatment resulting in an increased risk of inflammatory bowel disease in patients with immune disorders like psoriasis.

IL-17 Inhibitors Not Linked to IBD Risk in Patients with Immune Disorders

Patients with psoriatic arthritis often feel limited in their knowledge on medications and treatments, which investigators said leads to a lack of treatment and increased risk of disability.

Psoriatic Arthritis Shared Decision Making Burdened by Patient Fears, Uncertainties

A comparison of pooled phase 3 data showed patients treated with the IL-17A inhibitor fared better than those on ustekinumab, without influence from their PsA status.

Secukinumab Provides Psoriasis Skin Clearance Regardless of Psoriatic Arthritis Status

A post-hoc analysis shows that the human monoclonal antibody was linked to sustained improvements according to different disease measurements through week 52. 


Guselkumab May Provide Benefit for Psoriatic Arthritis Across Multiple Domains

A majority of studies reported a worsening of disease activity post-delivery.


Literature Review Explores Pregnancy Outcomes in Women with Psoriatic Arthritis

Upadacitinib Improved Psoriatic Arthritis Symptoms in Trial with Adalimumab

On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.